Helen Brady

A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

Paul W. Hollenbach, Aaron Nguyen, Helen Brady et al. · PLoS ONE · 2010 · 354 citations · Full text

Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity

Peter Schäfer, Anastasia Parton, Lori Capone et al. · Cellular Signalling · 2014 · 302 citations · Full text

A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor

L R Gooding, Lynne W. Elmore, Ann E. Tollefson et al. · Cell · 1988 · 249 citations

Tumor Necrosis Factor, Molecular Virology, Medicine +10

Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor Cells

Dominique Verhelle, Laura G. Corral, Kevin Wong et al. · Cancer Research · 2007 · 231 citations

Hematological Malignancy, Malignant B Cells, Bone Marrow Function +13

Targeting of TAK1 by the NF-κB protein Relish regulates the JNK-mediated immune response in <i>Drosophila</i>

Jin Mo Park, Helen Brady, Maria Grazia Ruocco et al. · Genes & Development · 2004 · 195 citations · Full text